rs367689657
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 1P and 6B. PP2BP4_ModerateBS2
The NM_003072.5(SMARCA4):c.1982G>A(p.Gly661Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000372 in 1,614,038 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_003072.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SMARCA4 | NM_001387283.1 | c.1982G>A | p.Gly661Asp | missense_variant | 13/36 | ENST00000646693.2 | NP_001374212.1 | |
SMARCA4 | NM_003072.5 | c.1982G>A | p.Gly661Asp | missense_variant | 13/35 | ENST00000344626.10 | NP_003063.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SMARCA4 | ENST00000646693.2 | c.1982G>A | p.Gly661Asp | missense_variant | 13/36 | NM_001387283.1 | ENSP00000495368.1 | |||
SMARCA4 | ENST00000344626.10 | c.1982G>A | p.Gly661Asp | missense_variant | 13/35 | 1 | NM_003072.5 | ENSP00000343896.4 | ||
SMARCA4 | ENST00000643549.1 | c.1982G>A | p.Gly661Asp | missense_variant | 13/35 | ENSP00000493975.1 | ||||
SMARCA4 | ENST00000541122.6 | c.1982G>A | p.Gly661Asp | missense_variant | 14/35 | 5 | ENSP00000445036.2 | |||
SMARCA4 | ENST00000643296.1 | c.1982G>A | p.Gly661Asp | missense_variant | 13/34 | ENSP00000496635.1 | ||||
SMARCA4 | ENST00000644737.1 | c.1982G>A | p.Gly661Asp | missense_variant | 13/34 | ENSP00000495548.1 | ||||
SMARCA4 | ENST00000589677.5 | c.1982G>A | p.Gly661Asp | missense_variant | 14/35 | 5 | ENSP00000464778.1 | |||
SMARCA4 | ENST00000643995.1 | c.1394G>A | p.Gly465Asp | missense_variant | 10/32 | ENSP00000496004.1 | ||||
SMARCA4 | ENST00000644963.1 | c.626G>A | p.Gly209Asp | missense_variant | 6/28 | ENSP00000495599.1 | ||||
SMARCA4 | ENST00000644065.1 | c.707G>A | p.Gly236Asp | missense_variant | 6/27 | ENSP00000493615.1 | ||||
SMARCA4 | ENST00000642350.1 | c.467G>A | p.Gly156Asp | missense_variant | 5/27 | ENSP00000495355.1 | ||||
SMARCA4 | ENST00000643857.1 | c.335G>A | p.Gly112Asp | missense_variant | 4/25 | ENSP00000494159.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152220Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000795 AC: 2AN: 251472Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135912
GnomAD4 exome AF: 0.00000342 AC: 5AN: 1461818Hom.: 0 Cov.: 31 AF XY: 0.00000413 AC XY: 3AN XY: 727230
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152220Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74370
ClinVar
Submissions by phenotype
Intellectual disability, autosomal dominant 16 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 15, 2021 | - - |
Rhabdoid tumor predisposition syndrome 2 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 20, 2023 | This sequence change replaces glycine, which is neutral and non-polar, with aspartic acid, which is acidic and polar, at codon 661 of the SMARCA4 protein (p.Gly661Asp). This variant is present in population databases (rs367689657, gnomAD 0.002%). This variant has not been reported in the literature in individuals affected with SMARCA4-related conditions. ClinVar contains an entry for this variant (Variation ID: 238385). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt SMARCA4 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Hereditary cancer-predisposing syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 16, 2024 | The c.1982G>A (p.G661D) alteration is located in exon 13 (coding exon 12) of the SMARCA4 gene. This alteration results from a G to A substitution at nucleotide position 1982, causing the glycine (G) at amino acid position 661 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at